1. Home
  2. NAUT vs MSD Comparison

NAUT vs MSD Comparison

Compare NAUT & MSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nautilus Biotechnolgy Inc.

NAUT

Nautilus Biotechnolgy Inc.

HOLD

Current Price

$1.03

Market Cap

125.4M

Sector

Industrials

ML Signal

HOLD

Logo Morgan Stanley Emerging Markets Debt Fund Inc.

MSD

Morgan Stanley Emerging Markets Debt Fund Inc.

HOLD

Current Price

$7.22

Market Cap

146.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAUT
MSD
Founded
2016
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Trusts Except Educational Religious and Charitable
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
125.4M
146.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
NAUT
MSD
Price
$1.03
$7.22
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
754.8K
43.4K
Earning Date
04-28-2026
01-01-0001
Dividend Yield
N/A
11.26%
EPS Growth
16.07
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$992.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$6.91
52 Week High
$4.31
$7.94

Technical Indicators

Market Signals
Indicator
NAUT
MSD
Relative Strength Index (RSI) 47.48 36.97
Support Level $0.84 $6.91
Resistance Level $2.30 $7.44
Average True Range (ATR) 0.09 0.06
MACD 0.04 -0.01
Stochastic Oscillator 46.35 0.00

Price Performance

Historical Comparison
NAUT
MSD

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

About MSD Morgan Stanley Emerging Markets Debt Fund Inc.

Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.

Share on Social Networks: